Targeted Therapies for Biliary Tract Cancers

Download this slideset for expert perspectives on best practices and emerging strategies in using immune checkpoint inhibitors and targeted therapies to treat patients with advanced biliary tract cancers.
Mark Yarchoan, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 2.35 MB
Released: November 12, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Genentech, a member of the Roche Group

Related Content

Slides from Clinical Care Options (CCO) on biomarker testing to guide targeted therapy for gastroesophageal cancers

Manish A. Shah, MD Released: January 21, 2022

Slides from Clinical Care Options (CCO) on biomarker testing to guide targeted therapy for pancreatic and biliary tract cancers

Rachna Shroff, MD Released: January 21, 2022

Slides from Clinical Care Options (CCO) on biomarker testing to guide targeted therapy for colorectal cancer (CRC)

John L. Marshall, MD Released: January 21, 2022

In this video from Clinical Care Options (CCO), Drs Michael Bishop, Jesús Berdeja, and Jae Park discuss key data on CAR T-cell therapy

Michael R. Bishop, MD
Program Director
person default Jesús G. Berdeja, MD Jae H. Park, MD
Physicians: maximum of 2.25 AMA PRA Category 1 Credits Released: January 13, 2022 Expired: January 12, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings